文章基本信息

标题：Association between long term exposure to particulate matter and incident hypertension in Spain
本地全文：下载
作者：Viyey Doulatram-Gamgaram ; Sergio Valdés ; Cristina Maldonado-Araque 等
期刊名称：Scientific Reports
电子版ISSN：2045-2322
出版年度：2021
卷号：11
DOI：10.1038/s41598-021-99154-7
语种：English
出版社：Springer Nature
摘要：Exposure to air particulate matter has been linked with hypertension and blood pressure levels. The metabolic risks of air pollution could vary according to the specific characteristics of each area, and has not been sufficiently evaluated in Spain. We analyzed 1103 individuals, participants in a Spanish nationwide population based cohort study ([email protected]), who were free of hypertension at baseline (2008–2010) and completed a follow-up exam of the cohort (2016–2017). Cohort participants were assigned air pollution concentrations for particulate matter < 10 μm (PM 10) and < 2.5 μm (PM 2.5) during follow-up (2008–2016) obtained through modeling combined with measurements taken at air quality stations (CHIMERE chemistry-transport model). Mean and SD concentrations of PM 10 and PM 2.5 were 20.17 ± 3.91 μg/m 3 and 10.83 ± 2.08 μg/m 3 respectively. During follow-up 282 cases of incident hypertension were recorded. In the fully adjusted model, compared with the lowest quartile of PM 10, the multivariate weighted ORs (95% CIs) for developing hypertension with increasing PM 10 exposures were 0.82 (0.59–1.14), 1.28 (0.93–1.78) and 1.45 (1.05–2.01) in quartile 2, 3 and 4 respectively ( p for a trend of 0.003). The corresponding weighted ORs according to PM 2.5 exposures were 0.80 (0.57–1.13), 1.11 (0.80–1.53) and 1.48 (1.09–2.00) ( p for trend 0.004). For each 5-μg/m 3 increment in PM 10 and PM 2.5 concentrations, the odds for incident hypertension increased 1.22 (1.06–1.41) p = 0.007 and 1.39 (1.07–1.81) p = 0.02 respectively. In conclusion, our study contributes to assessing the impact of particulate pollution on the incidence of hypertension in Spain, reinforcing the need for improving air quality as much as possible in order to decrease the risk of cardiometabolic disease in the population.